v3.26.1
Earnings Per Share (EPS) (Tables)
12 Months Ended
Dec. 31, 2025
Loss Per Share ("LPS")  
Schedule of computation of basic and diluted net loss per share attributable to common stockholders

The following table sets forth the computation of basic earnings per share attributable to common stockholders and the participating securities for the periods presented (in thousands, except share and per share data):

Basic LPS:

Successor

July 31, 2024 to December 31, 2024

(amounts in thousands, except share and per share data)

Common Shares

Convertible Securities Notes

Sponsor Earnout

Numerator:

Net loss allocated to each class of participating securities

$

(49,888)

$

$

(3,875)

Denominator:

Weighted-average shares outstanding

14,772,692

Shares issuable to Convertible Securities Notes

Sponsor Earnout

1,147,500

Net loss per share attributable to each class of participating securities – Basic

$

(3.38)

$

$

(3.38)

Successor

(amounts in thousands, except share and per share data)

Year Ended December 31, 2025

Numerator:

Net loss

$

(25,084)

Denominator:

Weighted-average shares outstanding used in computing net loss per share attributable to common stockholders - Basic

16,577,126

Net loss per share attributable to common stockholders - Basic

$

(1.51)

The following table sets forth the computation of basic loss per share attributable to common stockholders and the participating securities for the periods presented (in thousands, except share and per share data):

Diluted LPS:

Successor

Successor

(amounts in thousands, except share and per share data)

Year Ended December 31, 2025

July 31 to December 31

Numerator:

Net loss – Basic

$

(25,084)

$

(53,763)

Less: Adjustment for fair value changes to convertible securities notes

(929)

Net loss attributable to common stockholders – Diluted

$

(25,084)

$

(54,692)

Denominator:

Weighted-average shares outstanding – Basic

16,577,126

14,772,692

Weighted-average effect of shares issuable to Convertible Securities Notes (if-converted method)

Weighted-average shares outstanding – Diluted

16,577,126

14,772,692

Net loss per share attributable to common shares – Diluted (if-converted method)

$

(1.51)

$

(3.70)

Schedule of potentially dilutive securities were excluded from the computation of diluted net loss per share

Successor

Successor

December 31, 

December 31, 

2025

2024

2025 Milestone Warrants

18,038,829

Base Warrants

7,528,727

7,528,727

Convert Warrants

1,500,000

1,500,000

Earn-out Shares, subject to vesting conditions

1,147,500

1,147,500

Stock options issued in connection with the Business Combination

7,587

7,587

Total potentially dilutive securities

28,222,643

10,183,814

Adagio Medical Inc  
Loss Per Share ("LPS")  
Schedule of computation of basic and diluted net loss per share attributable to common stockholders

Predecessor

(amounts in thousands, except share and per share data)

January 1 to
July 30, 2024

Numerator:

Net loss attributable to common stockholders

$

(21,278)

Denominator:

Weighted-average shares outstanding used in computing net loss per share attributable to common stockholders - basic and diluted

815,854

Net income loss per share attributable to common stockholders - basic and diluted

$

(26.08)

Schedule of potentially dilutive securities were excluded from the computation of diluted net loss per share

Predecessor

   

As of
July 30, 2024

Convertible preferred stock

4,732,044

Stock options

740,409

Total potentially dilutive securities

5,472,453